Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

[Drugs against obesity].

¹Abt. für Endokrinologie und Stoffwechsel, Departement für Innere Medizin, Kantonsspital Basel.

Therapeutische Umschau. Revue Therapeutique

|August 1, 1990

Summary

Pharmacotherapy for obesity remains controversial, with many drugs lacking insurance coverage due to unproven efficacy. Fenfluramine shows modest weight loss but is effective only during use and may reduce cravings.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Tightly locked optical frequency comb from a semiconductor disk laser.

Optics express·2019

Same author

Programmable pulse shaping for time-gated amplifiers.

Optics express·2019

Same author

Sub-150-fs pulses from an optically pumped broadband modelocked integrated external-cavity surface emitting laser.

Optics letters·2019

Same author

High-power OPCPA generating 1.7 cycle pulses at 2.5 µm.

Optics express·2018

Same author

Orientation-dependent stereo Wigner time delay and electron localization in a small molecule.

Science (New York, N.Y.)·2018

Same author

Gas-lens effect in kW-class thin-disk lasers.

Optics express·2018

Area of Science:

Pharmacology
Obesity Management
Drug Efficacy

Background:

The role of pharmacotherapy in obesity treatment is debated.
Several drug classes have been explored for weight reduction.

Purpose of the Study:

To review the efficacy and side effects of various obesity pharmacotherapies.
To assess the current status and challenges of obesity pharmacotherapy in Switzerland.

Main Methods:

Review of available drug classes for obesity, including amphetamines, adrenergic drugs, serotonin agonists, and others.
Analysis of reported efficacy, side effects, and addiction potential.

Main Results:

Sympathomimetic drugs show significant side effects and addiction risks.
Fenfluramine, a serotoninergic agent, demonstrated modest but temporary weight-reducing effects.
Fenfluramine is relatively safe and may reduce carbohydrate cravings.

Conclusions:

Obesity pharmacotherapy efficacy is still under scrutiny by authorities, impacting insurance coverage.
Fenfluramine offers a potential option with a favorable side-effect profile, though its efficacy is limited to the duration of treatment.

Related Experiment Videos